Aarti Pharmalabs Limited (AARTIPHARM) — Defensive Interval Ratio
Aarti Pharmalabs Limited (AARTIPHARM) has a Defensive Interval Ratio of 347 days as of March 2025. Defensive assets of Rs6.26 Billion (cash Rs-, short-term investments Rs491.23 Million, receivables Rs5.76 Billion) cover 347 days of daily cash needs of Rs18.00 Million/day. See Aarti Pharmalabs Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Aarti Pharmalabs Limited Defensive Interval Ratio (2022–2025)
This chart shows how Aarti Pharmalabs Limited's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 347 days, meaning defensive assets of Rs6.26 Billion can fund 347 days of operations without new revenue. See AARTIPHARM net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Aarti Pharmalabs Limited (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Aarti Pharmalabs Limited from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AARTIPHARM stock market capitalisation.
| Year | DIR (days) | Defensive Assets (INR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 347 days | Rs6.26 Billion | Rs18.00 Million/day | Rs- | Rs491.23 Million | ▲ +31 days |
| 2024 | 316 days | Rs6.02 Billion | Rs19.02 Million/day | Rs- | Rs703.98 Million | ▲ +8 days |
| 2023 | 309 days | Rs5.08 Billion | Rs16.46 Million/day | Rs- | Rs509.90 Million | ▲ +64 days |
| 2022 | 245 days | Rs3.89 Billion | Rs15.91 Million/day | Rs- | Rs- | — |